Detection of the estrogen receptor and response to endocrine therapy in male breast cancer patients. 1977

Y Nomura, and H Kondo, and J Yamagata, and K Takenaka

The estrogen receptor was measured in breast cancer of two male patients. Both patients had a positive receptor content in their tumors. The dissociation constant and number of binding sites were both very similar to those in the female counterpart. In one of the patients, the number of binding sites in the metastatic lesions of the liver was similar to that in the primary site. The patient responded well to the endocrine ablation therapy with a remission period of 8 months. The estrogen receptor was found to be positive in 12 out of 14 cases of male breast cancer reported previously including the present 2 patients. Three out of 4 cases with positive receptor contnet, including the present case, responded to orchiectomy.

UI MeSH Term Description Entries
D008297 Male Males
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002293 Adenocarcinoma, Scirrhous An adenocarcinoma with a hard (Greek skirrhos, hard) structure owing to the formation of dense connective tissue in the stroma. (From Dorland, 27th ed) Carcinoma, Scirrhous,Adenocarcinomas, Scirrhous,Carcinomas, Scirrhous,Scirrhous Adenocarcinoma,Scirrhous Adenocarcinomas,Scirrhous Carcinoma,Scirrhous Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Y Nomura, and H Kondo, and J Yamagata, and K Takenaka
August 1981, Horumon to rinsho. Clinical endocrinology,
Y Nomura, and H Kondo, and J Yamagata, and K Takenaka
November 2009, Cancer science,
Y Nomura, and H Kondo, and J Yamagata, and K Takenaka
September 2006, Endocrine-related cancer,
Y Nomura, and H Kondo, and J Yamagata, and K Takenaka
April 1976, Virginia medical monthly,
Y Nomura, and H Kondo, and J Yamagata, and K Takenaka
September 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Y Nomura, and H Kondo, and J Yamagata, and K Takenaka
March 1980, European journal of cancer,
Y Nomura, and H Kondo, and J Yamagata, and K Takenaka
July 2016, Drug discovery today,
Y Nomura, and H Kondo, and J Yamagata, and K Takenaka
April 2011, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Y Nomura, and H Kondo, and J Yamagata, and K Takenaka
January 2018, Biological procedures online,
Copied contents to your clipboard!